| 000 | 03084nlm1a2200445 4500 | ||
|---|---|---|---|
| 001 | 660444 | ||
| 005 | 20231030041710.0 | ||
| 035 | _a(RuTPU)RU\TPU\network\29875 | ||
| 090 | _a660444 | ||
| 100 | _a20190702a2019 k y0engy50 ba | ||
| 101 | 0 |
_aeng _deng |
|
| 102 | _aUS | ||
| 135 | _adrcn ---uucaa | ||
| 181 | 0 | _ai | |
| 182 | 0 | _ab | |
| 200 | 1 |
_aThe Role of Humoral Factors in Producing the Cardioprotective Effect of Remote Ischemic Preconditioning _fE. S. Prokudina [et al.] |
|
| 203 |
_aText _celectronic |
||
| 300 | _aTitle screen | ||
| 320 | _a[References: 78 tit.] | ||
| 330 | _aThe humoral pathway mediating the cardioprotective effect of remote ischemic preconditioning has been demonstrated in various models: ischemia-reperfusion of the fore- and hindlimbs and liver and occlusion-reperfusion of the mesenteric and renal arteries. This review assesses humoral components in the formation and realization of the cardioprotective actions of remote ischemic preconditioning of the heart. Endogenous agonists of opioid receptors, arachidonic acid derivatives (prostanoids), agonists of cannabinoid and vanilloid receptors, calcitonin gene-related peptide, leukotrienes, and microRNA are all regarded as humoral components. Adenosine, which also has a role in mediating the cardioprotective effects of remote ischemic preconditioning, is regarded as a mediator between the humoral factor and cardiomyocytes. Knowledge of the role of humoral factors in mediating cardioprotection may be useful for developing methods and therapeutic agents to increase the resistance of the myocardium to ischemic-reperfusion damage. | ||
| 333 | _aРежим доступа: по договору с организацией-держателем ресурса | ||
| 461 |
_tNeuroscience and Behavioral Physiology _d1967- |
||
| 463 |
_tVol. 49, iss. 3 _v[P. 289–298] _d2019 |
||
| 610 | 1 | _aэлектронный ресурс | |
| 610 | 1 | _aтруды учёных ТПУ | |
| 610 | 1 | _aremote ischemic preconditioning | |
| 610 | 1 | _ahumoral factors | |
| 610 | 1 | _acardioprotection | |
| 610 | 1 | _aсердце | |
| 610 | 1 | _aишемическая болезнь | |
| 701 | 1 |
_aProkudina _bE. S. _gEkaterina Sergeevna |
|
| 701 | 1 |
_aMaslov _bL. N. _gLeonid Nikolaevich |
|
| 701 | 1 |
_aJaggi _bA. S. _gAmteshwar Singh |
|
| 701 | 1 |
_aPismenniy _bD. S. _gDmitry Sergeevich |
|
| 701 | 1 |
_aVoronkov _bN. S. _gNikita Sergeevich |
|
| 701 | 1 |
_aNesterov _bE. A. _cPhysicist, Specialist in the field of nuclear power engineering _cResearcher of Tomsk Polytechnic University _f1976- _gEvgeny Alexandrovich _2stltpush _3(RuTPU)RU\TPU\pers\32657 |
|
| 712 | 0 | 2 |
_aНациональный исследовательский Томский политехнический университет (ТПУ) _bФизико-технический институт (ФТИ) _bЛаборатория № 31 ядерного реактора (Лаборатория № 31 ЯР) _h6471 _2stltpush _3(RuTPU)RU\TPU\col\20054 |
| 801 | 2 |
_aRU _b63413507 _c20190702 _gRCR |
|
| 856 | 4 | _uhttps://doi.org/10.1007/s11055-019-00731-1 | |
| 942 | _cCF | ||